German Biotech Firm Expands to North Carolina's Life Sciences Hub

Coriolis Pharma opens new facility in Research Triangle Park to work directly with North American clients.

Mar. 11, 2026 at 10:03pm

Got story updates? Submit your updates here. ›

Coriolis Pharma, a German pharmaceutical company, has opened a new headquarters and lab in Research Triangle Park, North Carolina. The facility will allow the company to work directly with North American clients to develop and analyze biotech medicines. Experts cite the area's strong talent pipeline as a key factor attracting companies to the region, which has seen significant growth in the life sciences industry in recent years.

Why it matters

North Carolina's Research Triangle Park has become a global hub for the life sciences industry, attracting major investments and companies from around the world. The arrival of Coriolis Pharma further solidifies the region's status as a premier destination for biotech and pharmaceutical innovation.

The details

Coriolis Pharma's new facility in Research Triangle Park will allow the German company to work directly with North American clients on the development and analysis of biotech medicines. Experts attribute the area's strong talent pipeline, including partnerships with local community colleges like Durham Tech, as a key factor driving the life sciences industry's growth in the region.

  • In the past five years, North Carolina's life sciences industry has added thousands of jobs and nearly $10 billion in investment.
  • The $10 million Durham Tech health sciences facility is expected to begin operations in the first half of 2026 and create 50 new jobs.

The players

Coriolis Pharma

A German pharmaceutical company that has opened a new headquarters and lab in Research Triangle Park, North Carolina.

Silvia Steyrer-Gruber

The CEO of Coriolis Pharma.

Christian Brown

An expert from NCBiotech, a nonprofit organization that supports the life sciences industry in North Carolina.

Jerry Jones

A representative from Durham Tech, a community college that is helping to fuel the growth of the life sciences industry in the region.

Got photos? Submit your photos here. ›

What they’re saying

“There is a lot of potential that we can grow here.”

— Silvia Steyrer-Gruber, CEO, Coriolis Pharma

“All of that kind of mix really helps create an atmosphere that's very competitive and attractive for these types of companies.”

— Christian Brown, Expert, NCBiotech

“It's life-changing. To have RTP right outside our door and be able to direct our students to potential jobs, careers ... that adds to their resume along with their academic pursuit.”

— Jerry Jones, Representative, Durham Tech

What’s next

The $10 million Durham Tech health sciences facility is expected to begin operations in the first half of 2026 and create 50 new jobs.

The takeaway

North Carolina's Research Triangle Park has become a global hub for the life sciences industry, attracting major investments and companies from around the world. The arrival of Coriolis Pharma, a German pharmaceutical firm, further solidifies the region's status as a premier destination for biotech and pharmaceutical innovation, driven by a strong talent pipeline and partnerships with local educational institutions.